{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"5.670","rs_stock_flag":false,"fiscal_year_end":"2024年12月31日","hist_closedate":"2025年9月25日","replication_method":null,"amt_os":"235,703,422","primaryexch":"香港交易所","ric":"2185.HK","product_subtype":null,"db_updatetime":"2025年9月28日08:06","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.0,"inline_upper_strike_price":"","sedol":"BMWKKT0","am":"5.42","iv":"","ew_strike":"","as":"5.440","geographic_focus":null,"incorpin":"中華人民共和國","etp_baseCur":null,"ew_amt_os":"","bd":"5.380","registrar":"香港中央證券登記有限公司","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"100","update_time":"2025-09-28 00:06:03.0","lo52":"1.430","shares_issued_date":"2025年8月31日","premium":"","strike_price_ccy":null,"yield":"","vo_u":"K","base_currency":null,"coupon":"","expiry_date":"","chairman":"汪立","underlying_ric":"2185.HK","hi52":"10.770","issuer_name":"上海百心安生物技術股份有限公司 - B - H股","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"2025年9月26日16:08","aum_date":"","lo":"5.310","mkt_cap":"1.28","f_aum_hkd":null,"ew_sub_per_to":"","ls":"5.440","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"醫療保健業 - 其他醫療保健","ew_desc":null,"inception_date":"","nc":"-0.110","aum":"","issued_shares_class_B":null,"vo":"991.10","secondary_listing_flag":false,"listing_date":"2021年12月23日","issued_shares_class_A":null,"as_at_label":"截至","ew_amt_os_dat":"","nm":"上海百心安生物技術股份有限公司 - B - H股","nm_s":"百心安－Ｂ","sym":"2185","inline_lower_strike_price":"","listing_category":"主要上市","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"上海百心安生物技術股份有限公司是一家主要從事介入醫療業務的中國公司。該公司的主要業務是介入式心血管裝置的研發和生產。該公司的主要產品包括全降解支架（BRS）以及腎神經阻斷（RDN）。該公司的產品主要用於滿足治療冠狀、週邊動脈疾病及高血壓等的醫療需求。該公司的產品主要用於解決中國患者在治療冠狀動脈疾病方面的未滿足醫療需求，以及解決患者在治療未控高血壓方面未滿足的醫療需求。該公司主要在中國國內和海外市場開展業務。","op":"5.670","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"醫療設備及用品","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"中國上海市浦東新區<br/>張江高科技產業東區<br/>瑞慶路590號<br/>4幢3層302室","pc":"-1.98","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":"RMB","hdr":false,"launch_date":"","hc":"5.550","isin":"CNE100004JH3","moneyness":""}},"qid":"1759074447037"}
